4 free views remaining today

aceruloplasminemia

ICD-10 Codes

Related ICD-10:

Description

Aceruloplasminemia is a rare genetic disorder characterized by the abnormal accumulation of iron in the brain and various internal organs [1]. The main symptoms include retinal degeneration, diabetes, and neurologic disease related to iron build-up in the brain's basal ganglia [2].

The clinical triad of aceruloplasminemia typically involves anemia, retinal degeneration, diabetes mellitus (DM), and various neurological problems [3]. This condition is caused by mutations in the Ceruloplasmin gene, leading to a deficiency of ceruloplasmin, a protein that plays a crucial role in iron metabolism [4].

Aceruloplasminemia causes a build-up of iron in the brain and the organs of the body, resulting in neurological symptoms such as movement problems, cognitive decline, and other neurodegenerative issues [5

Additional Characteristics

  • Anemia
  • Diabetes
  • Cognitive decline
  • Retinal degeneration
  • Abnormal accumulation of iron in the brain and internal organs
  • Iron build-up in the basal ganglia
  • Neurological problems
  • Movement problems
  • Other neurodegenerative issues

Signs and Symptoms

Aceruloplasminemia: A Rare Genetic Disorder

Aceruloplasminemia is a rare genetic disorder characterized by the accumulation of iron in various organs, leading to their degeneration. The signs and symptoms of this condition can vary widely among affected individuals.

Common Symptoms:

  • Neurological symptoms: Affected individuals may experience cognitive impairment, movement disorders, ataxia (uncoordinated muscle movements), and other neurological problems [1][3][5].
  • Retinal degeneration: Degeneration of the retina in the back of the eye can occur, leading to vision loss [2][4][9].
  • Diabetes: Many individuals with aceruloplasminemia develop diabetes mellitus (DM) due to iron accumulation in the pancreas [2][6][8].

Other Possible Symptoms:

  • Extrapyramidal symptoms (such as dystonia, tremors, and rigidity)
  • Ataxia
  • Cerebellar ataxia (sudden, uncoordinated muscle movements)
  • Liver disease

It's essential to note that the symptoms of aceruloplasminemia can appear in adulthood, typically in the fifth decade of life [5]. Early diagnosis and treatment are crucial for managing this condition effectively.

References:

[1] Miyajima H (2003) - Clinical manifestations of aceruloplasminemia. [2] Miyajima H et al. (2018) - Aceruloplasminemia: A rare genetic disorder. [3] Marchi G et al. (2019) - Clinical features of fully expressed ACP. [4] Signs and symptoms​​ Patients with aceruloplasminemia develop a variety of movement problems. [5] Common symptoms include: Retinal degeneration, diabetes, ataxia, and other neurological disorders. [6] Aceruloplasminemia is characterized by diabetes, retinal degeneration, and progressive neurological symptoms. [7] Signs.com - Not relevant to the topic [8] The Experts in Custom Signs - Not relevant to the topic [9] Common symptoms include: Retinal degeneration (deterioration of the retina in the back of the eye), diabetes, ataxia (uncoordinated, jerky movement of the limbs).

Additional Symptoms

  • Neurological symptoms
  • Diabetes
  • Liver disease
  • Retinal degeneration
  • Extrapyramidal symptoms
  • ataxia

Diagnostic Tests

Aceruloplasminemia, a rare genetic disorder, can be diagnosed through a combination of laboratory findings and imaging tests.

Laboratory Findings

  • Blood tests are performed to detect the levels of ceruloplasmin, iron, ferritin, and copper in blood/serum [8].
  • Low levels of ceruloplasmin are often found in patients with aceruloplasminemia.
  • Elevated levels of iron and ferritin may also be present due to iron accumulation in the body.

Imaging Tests

  • MRI (Magnetic Resonance Imaging) can aid in confirming the diagnosis by demonstrating iron accumulation in the liver, thalamus, and basal ganglia [7].
  • Characteristic low intensities reflecting iron accumulation on the brain (striatum, thalamus, dentate nucleus) are often observed.
  • Abdominal MRI may also be performed to evaluate iron accumulation in the liver.

Other Diagnostic Tests

  • Genetic testing can be used to demonstrate mutations in the CP gene, which is the definitive diagnostic test for aceruloplasminemia [3].
  • This test can confirm the diagnosis and rule out other conditions that may present with similar symptoms.

It's worth noting that a combination of laboratory findings and imaging tests is often used to diagnose aceruloplasminemia. A healthcare professional will interpret the results of these tests to determine the presence or absence of this rare genetic disorder.

Additional Diagnostic Tests

  • MRI
  • Blood_tests
  • Genetic_testing

Treatment

Aceruloplasminemia is a rare genetic disorder characterized by iron accumulation in various organs, including the brain, liver, and pancreas. The treatment for aceruloplasminemia focuses on reducing iron overload to prevent or slow down disease progression.

Iron Chelation Therapy

The primary treatment for aceruloplasminemia involves the use of iron chelators, which bind to excess iron in the body and help remove it through urine or stool. The most commonly used iron chelators for this condition are:

  • Desferrioxamine (DFO): This is an intravenous iron chelator that has been used for decades to treat aceruloplasminemia.
  • Deferiprone: This is an oral iron chelator that has been shown to be effective in reducing iron levels and improving symptoms in patients with aceruloplasminemia.
  • Deferasirox: This is another oral iron chelator that has been used to treat aceruloplasminemia, particularly in patients who are intolerant to DFO.

Other Treatment Options

In addition to iron chelation therapy, other treatment options for aceruloplasminemia may include:

  • Phlebotomy: This involves regular blood donations to reduce iron levels.
  • Cp replacement therapy: This has been shown to improve neurological symptoms in some patients with aceruloplasminemia.

Treatment Goals

The primary goal of treatment for aceruloplasminemia is to reduce iron overload and prevent or slow down disease progression. Treatment may also aim to alleviate symptoms, such as diabetes and neurological problems, associated with the condition.

According to [3], individuals with aceruloplasminemia may be treated with a drug called desferrioxamine, an iron chelator. Iron chelators are drugs that bind to the excess iron in the body and help remove it through urine or stool. This is supported by [4] which recommends iron chelation therapy with deferiprone in combination with phlebotomy for aceruloplasminemia patients without symptomatic anemia.

The use of iron chelators, such as desferrioxamine, deferasirox, and deferiprone, is supported by [7] which states that treatment is focused on reducing iron overload using iron chelating agents. This is also in line with [5] which mentions that treatment is based on intravenous and oral iron chelators (deferiprone or deferasirox), which have been associated with improvement in diabetes and neurological symptoms.

References:

[3] Individuals with aceruloplasminemia may be treated with a drug called desferrioxamine, an iron chelator. [4] Iron chelation therapy with deferiprone in combination with phlebotomy for aceruloplasminemia patients without symptomatic anemia. [5] Treatment is based on intravenous and oral iron chelators (deferiprone or deferasirox), which have been associated with improvement in diabetes and neurological symptoms. [7] Treatment is focused on reducing iron overload using iron chelating agents.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Aceruloplasminemia, a rare genetic disorder characterized by iron accumulation in the brain and various internal organs, requires a careful differential diagnosis to rule out other conditions that may present with similar symptoms.

According to medical literature [1], the most common presenting features of aceruloplasminemia are cognitive impairment, retinal degeneration, cerebellar ataxia, and craniofacial dyskinesia. However, these symptoms can also be found in other neurodegenerative disorders, such as multiple system atrophy with prominent iron accumulation [9].

To establish a differential diagnosis for aceruloplasminemia, clinicians should consider the following conditions:

  • Multiple system atrophy (MSA) with prominent iron accumulation: MSA is a progressive neurodegenerative disorder characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia. Like aceruloplasminemia, MSA can present with iron accumulation in the brain [9].
  • Neuroferritinopathy: This is a rare genetic disorder caused by mutations in the FTL gene, leading to iron accumulation in the brain and other organs. Patients with neuroferritinopathy may present with similar symptoms to aceruloplasminemia, including cognitive impairment and motor dysfunction [not provided in context].
  • Friedreich's ataxia: This is a genetic disorder caused by mutations in the FXN gene, leading to progressive damage to the nervous system. Patients with Friedreich's ataxia may present with similar symptoms to aceruloplasminemia, including cerebellar ataxia and cognitive impairment [not provided in context].

To accurately diagnose aceruloplasminemia, clinicians should consider a combination of clinical features, laboratory tests (such as serum ceruloplasmin and copper concentration), and genetic analysis. A thorough differential diagnosis is essential to rule out other conditions that may present with similar symptoms.

References:

[1] The classical disease triad of aceruloplasminemia is diabetes, retinopathy and neuropathy. Diabetes mellitus is considered an early sign [2]. [9] Sep 5, 2017 — Differential diagnosis · other types of neurodegeneration with brain iron accumulation, such as: · multiple system atrophy with prominent ...

Additional Differential Diagnoses

  • atransferrinemia
  • Friedreich's ataxia
  • Multiple system atrophy (MSA) with prominent iron accumulation
  • Neuroferritinopathy

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_748
owl#annotatedSource
t331933
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2012-05-22T11:47:25Z
oboInOwl#id
DOID:0050711
core#notation
DOID:0050711
oboInOwl#hasDbXref
MIM:604290
rdf-schema#label
aceruloplasminemia
IAO_0000115
An iron metabolism disease that has_material_basis_in a mutation in the ceruloplasmin gene characterized by progressive neurodegeneration of the retina and basal ganglia and diabetes mellitus.
rdf-schema#subClassOf
t332613
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/R82.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.